boosting Oncology investigation with built-in KRAS Assay solutions and RAS Assays
In the speedily evolving field of oncology investigation, correct and efficient mutation screening is crucial for building targeted therapies. The KRAS providers System plays a pivotal position On this landscape by presenting thorough alternatives for KRAS mutation profiling and Evaluation. KRAS mutations, present in about 95% of RAS-relevant oncog